Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Goblet cell loss abrogates ocular surface immune tolerance
Byung Yi Ko, Yangyan Xiao, Flavia L. Barbosa, Cintia S. de Paiva, Stephen C. Pflugfelder
Byung Yi Ko, Yangyan Xiao, Flavia L. Barbosa, Cintia S. de Paiva, Stephen C. Pflugfelder
View: Text | PDF
Research Article Angiogenesis Immunology

Goblet cell loss abrogates ocular surface immune tolerance

  • Text
  • PDF
Abstract

Intestinal epithelial cells condition tolerogenic properties in DCs. Aqueous-deficient dry eye is associated with goblet cell (GC) loss and increased IFN-γ expression in the conjunctiva. We hypothesized that loss of GCs reduces tolerance-inducing properties of antigen presenting cells (APCs) in the conjunctiva and draining nodes. Mice lacking the SAM pointed domain containing ETS transcription factor (Spdef) that is required for GC differentiation had an increased frequency of macrophages in the conjunctiva and CD11b+CD11c+ DCs in the conjunctiva and draining nodes, and these cells had greater IL-12 expression than WT mice. Conditioned media from cultured WT conjunctival GCs suppressed LPS-induced IL-12 production by conjunctival APCs. OVA antigen–specific OTII CD4+ T cells primed by Spdef-KO draining lymph node APCs showed greater proliferation, lower frequency of Foxp3+, increased frequency of IFN-γ+ and IL-17+ cells, and greater IFN-γ production than those primed by WT APCs. The immune tolerance to OVA antigen topically applied to the conjunctiva measured by cutaneous delayed type hypersensitivity (DTH) reaction, OVA-specific T cell proliferation, Foxp3 induction, and IFN-γ production observed in WT mice was lost in the Spdef-KO mice. We concluded that conjunctival GCs condition tolerogenic properties in APCs that suppress IL-12 production and Th1 polarization.

Authors

Byung Yi Ko, Yangyan Xiao, Flavia L. Barbosa, Cintia S. de Paiva, Stephen C. Pflugfelder

×

Figure 2

Spdef-KO DCs prime Th1 and Th17 responses.

Options: View larger image (or click on image) Download as PowerPoint
Spdef-KO DCs prime Th1 and Th17 responses.
CLN suspensions were pulsed w...
CLN suspensions were pulsed with OVA peptide for 1 hour prior to addition of OTII CFSE–labeled CD4+ T cells. After 4–5 days, cells were collected, intracellular staining was investigated by flow cytometry, and IFN-γ immunobead assay was performed in culture supernatants. (A) Representative histogram of CFSE median fluorescence intensity (MFI) in WT and Spdef-KO groups. (B) Flow cytometry dot plots of intracellular staining for Foxp3, IFN-γ, or IL-17 in CFSE lowCD4+ OTII T cells after 4 days in culture (n = 3/group). (C) Production of IFN-γ was measured by Luminex assay of coculture supernatants. Bar graph presents mean ± SEM (n = 10). *P = 0.03. Between-group comparisons were performed with the Mann-Whitney test. Results from a repeat experiment showed similar between-group difference.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts